跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-ROSUVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-ROSUVASTATIN
Authorized
STANDARD
M-ROSUVASTATIN
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6a7adbfd112558b3
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
6a7adbfd112558b3
Drug Approval Canada Name
M-ROSUVASTATIN
Product Name
M-ROSUVASTATIN
Status
Marketed
Status Date
2023-12-21
Original Market Date
2020-08-25
Din
02496534
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA07 ROSUVASTATIN
Atc Name
c 10 aa 07
Aig Number
0148963004
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
ROSUVASTATIN (ROSUVASTATIN CALCIUM)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6a7adbfd112558b3
Type
Standard
Back to Health Canada Approvals